Cancer Immunotherapy Stocks List

Recent Signals

Date Stock Signal Type
2020-08-03 ADAP Fell Below 20 DMA Bearish
2020-08-03 ADAP Bollinger Band Squeeze Range Contraction
2020-08-03 ADRO 20 DMA Support Bullish
2020-08-03 ADRO New Uptrend Bullish
2020-08-03 ADRO Bollinger Band Squeeze Range Contraction
2020-08-03 ALXO New 52 Week Closing High Bullish
2020-08-03 ALXO Hot IPO Pullback Bullish Swing Setup
2020-08-03 BCEL Narrow Range Bar Range Contraction
2020-08-03 BCEL NR7 Range Contraction
2020-08-03 CLBS 20 DMA Resistance Bearish
2020-08-03 CLBS Crossed Above 200 DMA Bullish
2020-08-03 CLBS NR7 Range Contraction
2020-08-03 CRVS 20 DMA Resistance Bearish
2020-08-03 HARP Slingshot Bearish Bearish Swing Setup
2020-08-03 IOVA Pocket Pivot Bullish Swing Setup
2020-08-03 IOVA Bollinger Band Squeeze Range Contraction
2020-08-03 IOVA Crossed Above 50 DMA Bullish
2020-08-03 IOVA Crossed Above 20 DMA Bullish
2020-08-03 MBIO 50 DMA Resistance Bearish
2020-08-03 MBIO Pocket Pivot Bullish Swing Setup
2020-08-03 MBIO Crossed Above 20 DMA Bullish
2020-08-03 MBIO Stochastic Buy Signal Bullish
2020-08-03 MBIO Crossed Above 200 DMA Bullish
2020-08-03 MRUS Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2020-08-03 MRUS NR7 Range Contraction
2020-08-03 NLTX Crossed Above 200 DMA Bullish
2020-08-03 PDSB 180 Bullish Setup Bullish Swing Setup
2020-08-03 RCUS Jack-in-the-Box Bearish Bearish Swing Setup
2020-08-03 RCUS Lower Bollinger Band Walk Weakness
2020-08-03 RCUS Stochastic Buy Signal Bullish
2020-08-03 SURF Narrow Range Bar Range Contraction
2020-08-03 SURF Bollinger Band Squeeze Range Contraction
2020-08-03 SURF MACD Bearish Centerline Cross Bearish
2020-08-03 SURF 50 DMA Resistance Bearish
2020-08-03 SURF NR7 Range Contraction
2020-08-03 ZYME MACD Bullish Signal Line Cross Bullish
2020-08-03 ZYME Crossed Above 20 DMA Bullish
2020-08-03 ZYME Non-ADX 1,2,3,4 Bearish Bearish Swing Setup

Cancer immunotherapy (sometimes called immuno-oncology) is the artificial stimulation of the immune system to treat cancer, improving on the system's natural ability to fight cancer. It is an application of the fundamental research of cancer immunology and a growing subspecialty of oncology. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules (e.g. carbohydrates). Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill.

More about Cancer Immunotherapy